The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

Moving (re-shaping) the mitral annulus

EuroIntervention 2021;16:1044-1045. DOI: 10.4244/EIJV16I13A190

1. University Hospital Bonn, Bonn, Germany


The therapeutic gold standard for the treatment of severe mitral regurgitation (MR) is elimination of MR by reduction of mitral annular anteroposterior (AP) diameter with direct surgical annuloplasty. However, open heart surgery is declined in many high-risk heart failure (HF) patients who are still symptomatic from MR despite medication.

During the last decade, transcatheter mitral valve repair (TMVr) approaches have earned merit in terms of reduction of MR. Despite excellent echocardiographic and clinical results after MitraClip® (Abbott Vascular, Santa Clara, CA, USA) or PASCAL (Edwards Lifesciences, Irvine, CA, USA) procedures, edge-to-edge TMVr has limitations with about 10-20% ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Smoke signals – do they help to predict TAVI-associated stroke risk?